ATE302765T1 - 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung - Google Patents
2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendungInfo
- Publication number
- ATE302765T1 ATE302765T1 AT02700318T AT02700318T ATE302765T1 AT E302765 T1 ATE302765 T1 AT E302765T1 AT 02700318 T AT02700318 T AT 02700318T AT 02700318 T AT02700318 T AT 02700318T AT E302765 T1 ATE302765 T1 AT E302765T1
- Authority
- AT
- Austria
- Prior art keywords
- arylimino
- production
- therapeutic use
- dihydrothiazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Developing Agents For Electrophotography (AREA)
- Liquid Crystal (AREA)
- Thin Film Transistor (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0100396A FR2819508B1 (fr) | 2001-01-12 | 2001-01-12 | Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques |
PCT/FR2002/000093 WO2002055510A1 (fr) | 2001-01-12 | 2002-01-11 | Derives de 2-arylimino-2,3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE302765T1 true ATE302765T1 (de) | 2005-09-15 |
Family
ID=8858747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02700318T ATE302765T1 (de) | 2001-01-12 | 2002-01-11 | 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung |
Country Status (26)
Country | Link |
---|---|
US (1) | US7220765B2 (fr) |
EP (1) | EP1353912B1 (fr) |
JP (1) | JP4452443B2 (fr) |
KR (1) | KR100874298B1 (fr) |
CN (1) | CN100534988C (fr) |
AR (1) | AR035730A1 (fr) |
AT (1) | ATE302765T1 (fr) |
AU (1) | AU2002233407B2 (fr) |
BR (1) | BR0206407A (fr) |
CA (1) | CA2434203C (fr) |
CZ (1) | CZ20031917A3 (fr) |
DE (1) | DE60205717T2 (fr) |
DK (1) | DK1353912T3 (fr) |
ES (1) | ES2248514T3 (fr) |
FR (1) | FR2819508B1 (fr) |
HU (1) | HUP0500958A3 (fr) |
IL (2) | IL156647A0 (fr) |
IS (1) | IS2331B (fr) |
MX (1) | MXPA03006249A (fr) |
MY (1) | MY142762A (fr) |
NO (1) | NO325484B1 (fr) |
NZ (1) | NZ526692A (fr) |
PL (1) | PL367627A1 (fr) |
RU (1) | RU2283838C2 (fr) |
WO (1) | WO2002055510A1 (fr) |
ZA (1) | ZA200305100B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005030740A1 (fr) * | 2003-09-30 | 2005-04-07 | Takeda Pharmaceutical Company Limited | Derive thiazoline et utilisation |
JP4896387B2 (ja) * | 2003-09-30 | 2012-03-14 | 武田薬品工業株式会社 | チアゾリン誘導体およびその用途 |
EP1926706B1 (fr) * | 2005-09-13 | 2012-03-21 | Bayer CropScience AG | Dérivés de biphénylamidine comme pesticides |
KR100863239B1 (ko) * | 2007-05-23 | 2008-10-15 | 한국과학기술연구원 | 신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는t-형 칼슘 채널 저해제 |
EP2301950A4 (fr) * | 2008-06-23 | 2014-06-11 | Tosoh Corp | Agent de séparation pour la purification d une protéine et procédé de purification d une protéine |
KR101049935B1 (ko) | 2008-12-03 | 2011-07-15 | 한국과학기술연구원 | 신규한 티아졸린계 화합물 및 이를 포함하는 t-형 칼슘 채널 저해제 |
ES2351569B8 (es) * | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
RU2562833C2 (ru) * | 2010-08-09 | 2015-09-10 | НБ Хелс Лаборатори Ко. Лтд. | Ингибитор казеинкиназы 1 дельта и казеинкиназы 1 е |
RU2521390C1 (ru) * | 2013-03-14 | 2014-06-27 | Общество с ограниченной ответственностью "Тиацен" | Производное роданина и средство для профилактики опухолевых заболеваний |
EP3498717B1 (fr) | 2016-08-12 | 2022-05-04 | The Catholic University of Korea Industry-Academic Cooperation Foundation | Composition pour le durcissement de tissu mou |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1347371A (fr) * | 1962-01-19 | 1963-12-27 | Ciba Geigy | Agents de lutte contre les organismes nuisibles, renfermant des thiazolines, à usages agricoles et industriels |
DE2926771A1 (de) * | 1979-07-03 | 1981-01-15 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
DE3049460A1 (de) * | 1980-12-30 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | "thiazolinderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
FR2735777B1 (fr) * | 1995-06-21 | 1997-09-12 | Sanofi Sa | Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
FR2796643B1 (fr) * | 1999-07-22 | 2005-04-29 | Sod Conseils Rech Applic | Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique |
-
2001
- 2001-01-12 FR FR0100396A patent/FR2819508B1/fr not_active Expired - Fee Related
- 2001-12-27 MY MYPI20015897A patent/MY142762A/en unknown
-
2002
- 2002-01-11 AT AT02700318T patent/ATE302765T1/de not_active IP Right Cessation
- 2002-01-11 AR ARP020100094A patent/AR035730A1/es unknown
- 2002-01-11 AU AU2002233407A patent/AU2002233407B2/en not_active Ceased
- 2002-01-11 CZ CZ20031917A patent/CZ20031917A3/cs unknown
- 2002-01-11 DK DK02700318T patent/DK1353912T3/da active
- 2002-01-11 ES ES02700318T patent/ES2248514T3/es not_active Expired - Lifetime
- 2002-01-11 CN CNB02803662XA patent/CN100534988C/zh not_active Expired - Fee Related
- 2002-01-11 MX MXPA03006249A patent/MXPA03006249A/es active IP Right Grant
- 2002-01-11 CA CA2434203A patent/CA2434203C/fr not_active Expired - Fee Related
- 2002-01-11 IL IL15664702A patent/IL156647A0/xx unknown
- 2002-01-11 EP EP02700318A patent/EP1353912B1/fr not_active Expired - Lifetime
- 2002-01-11 BR BR0206407-3A patent/BR0206407A/pt not_active IP Right Cessation
- 2002-01-11 KR KR1020037009303A patent/KR100874298B1/ko not_active IP Right Cessation
- 2002-01-11 RU RU2003124749/04A patent/RU2283838C2/ru not_active IP Right Cessation
- 2002-01-11 NZ NZ526692A patent/NZ526692A/en unknown
- 2002-01-11 DE DE60205717T patent/DE60205717T2/de not_active Expired - Lifetime
- 2002-01-11 PL PL02367627A patent/PL367627A1/xx not_active Application Discontinuation
- 2002-01-11 JP JP2002556180A patent/JP4452443B2/ja not_active Expired - Fee Related
- 2002-01-11 WO PCT/FR2002/000093 patent/WO2002055510A1/fr active IP Right Grant
- 2002-01-11 HU HU0500958A patent/HUP0500958A3/hu unknown
-
2003
- 2003-06-25 IL IL156647A patent/IL156647A/en not_active IP Right Cessation
- 2003-06-30 ZA ZA200305100A patent/ZA200305100B/en unknown
- 2003-07-08 US US10/615,481 patent/US7220765B2/en not_active Expired - Fee Related
- 2003-07-08 NO NO20033120A patent/NO325484B1/no not_active IP Right Cessation
- 2003-07-09 IS IS6870A patent/IS2331B/is unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60313602D1 (de) | N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG | |
DE10393704D2 (de) | Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung | |
ATE347890T1 (de) | Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren | |
ATE263754T1 (de) | Substituierte sulfonylaminomethylbenzoesäure(derivate) und verfahren zu ihrer herstellung | |
DE50011035D1 (de) | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE502004011957D1 (de) | Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE60233058D1 (de) | Silsesquioxanderivate und verfahren zu ihrer herstellung | |
DE50312949D1 (de) | Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung | |
ATE348609T1 (de) | Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
ATE327981T1 (de) | Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
DE50310782D1 (de) | Piezoaktor und verfahren zu dessen herstellung | |
DE60103395D1 (de) | 1,4-diazabicyclo[3.2.2]nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
DE50011818D1 (de) | Hochkratzfeste mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung | |
DE60224880D1 (de) | Mikrobolometer und verfahren zu dessen herstellung | |
DE50011179D1 (de) | Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE60205717D1 (de) | 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
DE50310320D1 (de) | Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung | |
DE60122295D1 (de) | Flavon derivate, verfahren zu deren herstellung und deren verwendung als heilmittel | |
ATE313556T1 (de) | Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung | |
ATE288442T1 (de) | Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben | |
DE602004026157D1 (de) | Proteinkomplex, verfahren zu dessen herstellung und verwendung davon | |
DE50110363D1 (de) | Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben | |
ATE356120T1 (de) | 2-phenyl-benzofuran-derivate, verfahren zur ihrer herstellung und ihre verwendung | |
DE60015806D1 (de) | Poly-3-cyclopropyl-3-hydroxypropionat und verfahren zu seiner herstellung und derivate daraus | |
DE50213487D1 (de) | C2-substituierte indan-1-ole und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1353912 Country of ref document: EP |
|
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |